Nurse-Led Telemonitoring for Chronic Conditions
What You Need to Know Before You Apply
What is the purpose of this trial?
The trial aims to test a new approach for assisting individuals with complex chronic conditions such as heart failure, diabetes, or depression. It focuses on telemonitoring, using a smartphone app to track symptoms and send alerts to healthcare providers when necessary. This method could enhance care coordination and ensure patients receive needed assistance between doctor's visits. Individuals who have been hospitalized and have one of these chronic conditions might be suitable candidates, particularly if they can use a smartphone app to monitor their health. As an unphased trial, this study offers participants the chance to contribute to innovative healthcare solutions and improve their own care management.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your medications, as the trial focuses on telemonitoring for chronic conditions.
What prior data suggests that telemonitoring is safe for managing chronic conditions?
Research has shown that telemonitoring is generally safe for managing long-term health conditions. Studies have found that telemonitoring can lower the risk of death and hospital visits for patients with heart failure. By monitoring symptoms and notifying healthcare providers when necessary, it allows for quick action.
A review of multiple studies found that patients using telemonitoring devices often experience better outcomes, such as lower death rates, compared to those who do not use them. This suggests the technology is not only effective but also well-accepted by patients.
While every treatment has potential risks, current evidence indicates that telemonitoring is a safe option for managing chronic diseases like heart failure, diabetes, and COPD (chronic obstructive pulmonary disease). Those considering joining a trial involving telemonitoring can feel confident about its safety based on past research findings.12345Why are researchers excited about this trial?
Researchers are excited about telemonitoring for chronic conditions because it offers a new way to manage multiple health issues like heart failure, diabetes, depression, hypertension, and COPD using a smartphone app. Unlike traditional treatments that rely on regular in-person visits to track symptoms and adjust care, this approach allows patients to monitor and report their symptoms daily from home. The app, Medly MCC, sends this data wirelessly to healthcare providers, who can respond promptly if needed, and provides patients with personalized self-care messages. This could lead to faster, more personalized care and better health outcomes by catching potential problems early.
What evidence suggests that telemonitoring is effective for managing chronic conditions?
This trial will compare a nurse-led telemonitoring system, specifically the Medly MCC, with standard care. Research has shown that telemonitoring systems like the Medly MCC can help manage long-term health issues. Studies have found that using telemonitoring can lower the chances of death and hospital visits for people with heart failure. It also helps track conditions like diabetes, high blood pressure, and COPD, allowing for quick medical responses. Specifically, people with chronic heart failure who use this technology have shown lower death rates. This system enables healthcare providers to monitor symptoms daily and alerts them when medical help might be needed, improving overall patient care.23678
Who Is on the Research Team?
Emily Seto, PhD
Principal Investigator
University of Toronto
Are You a Good Fit for This Trial?
The SMaRT Study is for adults over 18 who have recently been discharged from certain hospitals in Canada and have at least one chronic condition like heart failure, COPD, high blood pressure, diabetes, or depression. Participants need to be able to use the telemonitoring app and devices (like a weight scale) and speak English or have someone who can communicate for them.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Design and Development
Design and development of the SMaRT Clinic model and telemonitoring system
Implementation and Effectiveness Evaluation
Implementation of the SMaRT Clinics and evaluation of their effectiveness through various research activities
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Telemonitoring
Find a Clinic Near You
Who Is Running the Clinical Trial?
University Health Network, Toronto
Lead Sponsor
Markham Stouffville Hospital
Collaborator
Health Sciences North
Collaborator
William Osler Health System
Collaborator
Women's College Hospital
Collaborator